Log in

ASX:CGSCogState Stock Price, Forecast & News

A$0.34
+0.01 (+3.08 %)
(As of 05/13/2020)
Add
Compare
Today's Range
A$0.33
Now: A$0.34
A$0.34
50-Day Range
A$0.31
MA: A$0.33
A$0.36
52-Week Range
A$0.15
Now: A$0.34
A$0.59
Volume2,002 shs
Average VolumeN/A
Market Capitalization$57.00 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain injury applications in Australia and internationally. The company's services include scientific consultancy, project management, data management, statistical analysis, and reporting. It operates in three segments: Clinical Trials, Academic Research, and Healthcare. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Academic Research segment offers technology and associated services to support international research studies and academic collaborations across various indications, including Alzheimer's disease, HIV, multiple sclerosis, pediatric and adult oncology, Parkinson's disease, epilepsy, and schizophrenia. As of June 30, 2018, it had participated in approximately 1,200 academic research studies in approximately 70 indications. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist in the early detection of cognitive decline. The company serves biopharmaceutical companies, sporting organizations, military, physicians and patients, academic institutions, and public-private partnerships. Cogstate Limited was founded in 1999 and is headquartered in Melbourne, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.12 out of 5 stars


Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
CIKN/A
Phone61 3 9664 1300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$20.41 million
Cash FlowA$0.04 per share
Book ValueA$0.09 per share

Profitability

Miscellaneous

Employees152
Market Cap$57.00 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CGS News and Ratings via Email

Sign-up to receive the latest news and ratings for CGS and its competitors with MarketBeat's FREE daily newsletter.

CogState (ASX:CGS) Frequently Asked Questions

How has CogState's stock been impacted by COVID-19 (Coronavirus)?

CogState's stock was trading at A$0.45 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CGS stock has decreased by 25.6% and is now trading at A$0.34. View which stocks have been most impacted by Coronavirus.

Has CogState been receiving favorable news coverage?

News stories about CGS stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research group rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. CogState earned a coverage optimism score of 1.6 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutCogState.

Who are some of CogState's key competitors?

Who are CogState's key executives?

CogState's management team includes the following people:
  • Mr. Bradley O'Connor C.A., B.Bus, CA, CEO, MD & Exec. Director
  • Dr. Paul Maruff BBSc (Hons), Ph.D., Chief Scientific Officer
  • Mr. Lammert Albers, Chief Commercial Officer
  • Mr. Frank Cheng, Pres of Healthcare
  • Ms. Claire Newstead-Sinclair C.A., BBus, CA, Fin. Mang. & Company Sec.

What is CogState's stock symbol?

CogState trades on the ASX under the ticker symbol "CGS."

What is CogState's stock price today?

One share of CGS stock can currently be purchased for approximately A$0.34.

How big of a company is CogState?

CogState has a market capitalization of $57.00 million and generates $20.41 million in revenue each year. CogState employs 152 workers across the globe.

What is CogState's official website?

The official website for CogState is www.cogstate.com.

How can I contact CogState?

The company can be reached via phone at 61 3 9664 1300.

This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.